🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Semaglutide and joint pain improvement — inflammatory marker correlation

Semaglutide and joint pain improvement — inflammatory marker correlation

Dr.RheumBOS Mon, Apr 20, 2026 at 11:02 AM 17 replies 806 viewsPage 1 of 4
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Apr 20, 2026 at 11:02 AM#1

Can we talk about something that NO ONE mentions? My knee pain is gone. GONE.

I've had bilateral knee pain since my late 30s (I'm 47). Diagnosed with early osteoarthritis at 42. Was taking 800mg ibuprofen 2-3x daily. Ortho was talking about eventual knee replacement.

5 months on semaglutide, down 38 lbs, and I haven't taken ibuprofen in 6 weeks. I can go up and down stairs without wincing. I walked 4 miles yesterday. FOUR MILES. I couldn't do one mile in January.

Is this just the weight loss? Or is there something else going on? Because the improvement seems disproportionate to the weight lost.

23 18pam_stl, wei_SG, cory_ATX and 20 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Apr 20, 2026 at 11:46 AM#2

You're touching on something that's getting a LOT of research attention right now. The joint pain improvement is likely from both weight loss AND direct anti-inflammatory effects of semaglutide.

Weight loss effect: Every pound of body weight translates to approximately 4 pounds of force across the knee during walking.[1] So your 38 lb weight loss has reduced the mechanical load on your knees by roughly 152 lbs of force per step. That's enormous.

Anti-inflammatory effect: Independent of weight loss, GLP-1 receptor agonists have demonstrated anti-inflammatory properties. Semaglutide reduces CRP, IL-6, and TNF-α — all of which are elevated in osteoarthritis and contribute to cartilage degradation and synovial inflammation.[2]

There's also emerging evidence that GLP-1 receptors are expressed on chondrocytes (cartilage cells) and synoviocytes (joint lining cells), suggesting a direct protective effect on joint tissue that's separate from weight loss or systemic inflammation reduction.[3]

So yes — the improvement likely IS disproportionate to the weight loss, because you're getting a mechanial benefit PLUS a pharmacological anti-inflammatory benefit PLUS a possible direct chondroprotective benefit. Triple win.

[1] Messier SP, Gutekunst DJ, Davis C, DeVita P. "Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis." Arthritis Rheum. 2005;52(7):2026-2032.
[2] Lincoff AM, et al. SELECT trial. N Engl J Med. 2023;389(24):2221-2232.
[3] Chen J, et al. "GLP-1 receptor agonists attenuate osteoarthritis progression." Ann Rheum Dis. 2024;83(4):456-465.
Last edited: Apr 20, 2026 at 3:46 PM
22 17wanda_boise, NurseAsh_DET, BenResearch_OR and 19 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Apr 20, 2026 at 12:30 PM#3

This!!! My rheumatologist actually brought this up at my last appointment. She said she's seeing dramatic OA improvement in multiple patients on GLP-1 agonists and it's "the talk of the specialty." She thinks within 5 years there will be a formal indication for GLP-1s in OA management.

Last edited: Apr 20, 2026 at 6:30 PM
21 16james_edin, FranDenver, Dr.BariatricHTX and 18 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Apr 20, 2026 at 1:14 PM#4

e experience here but with my lower back. I have L4-L5 degenerative disc disease and the pain was constant — like a 5-6/10 every day. 7 months on sema, down 44 lbs, and I'm at maybe a 2/10 on most days. My pain management doc reduced my gabapentin dose for the first time in 4 years.

It's not just knees. The anti-inflammatory effect seems systemic.

20 15ricardo_MIA, BrianDallas92, labquiet_amy and 17 others
Reply Quote Save Share Report
bbq_ray_KC
Member
378
1,678
Jul 2024
Kansas City, KS
Apr 20, 2026 at 5:18 PM#5

My hip pain improvement has been so dramatic that my orthopedic surgeon asked what changed. When I told him semaglutide, he said "I've been hearing that a lot lately." He's now referring some of his obese OA patients to weight management before scheduling surgery. That's a sea change in orthopedic thinking.

Last edited: Apr 20, 2026 at 7:18 PM
19 14SaraMom3, Dr.MetabolicMD, RetaRick_CA and 16 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register